Building on our solid operations in Europe, we are committed to creating a strong and sustainable clinical research infrastructure and bringing world-class health research skills and clinical trial execution to Africa
Our Brand Promise
We help advance health
through data excellence
- We specialise in public health, clinical and epidemiological research.
- We have a strong track record of collaborating with both private and public partners globally.
- We contribute to the collection, management and reporting of robust and reliable data that impact people’s lives around the world.
See below to learn more about our new identity.
Our identity
Our Solutions

Interventional Studies
Planning and execution of your early stage trials to ensure timely completion of your clinical development programmes.

Capacity Building

Observational Studies

Implementation Research
Recent Blog Posts
World Neglected Tropical Diseases Day 2026 | 30 January
Neglected tropical diseases remain a daily reality for more than one billion people worldwide. Yet they are among the most solvable challenges in global health. With proven tools, coordinated action, and sustained commitment, NTDs can be prevented, treated, and...
January 2026 Newsletter: Happy New Year from Pharmalys!
We hope you all enjoyed a restful festive period and feel energised for the year ahead. At Pharmalys, we enter 2026 with the same sense of readiness and purpose, having wrapped up 2025 with our Annual Meeting (pictured above), which provided an opportunity to reflect...
Pharmalys at the World Vaccine Congress Europe 2025: Marieme Ba calls for a “Come and Build” Approach to Strengthening LMICs Clinical Research Ecosystems
From 13 to 16 October 2025, Pharmalys Founder & CEO Marieme Ba attended the World Vaccine Congress Europe in Amsterdam, one of the most influential global gatherings for vaccine development, innovation, and cross-sector collaboration. This year’s edition brought...



